Our initial experience with examination of antibodies against Saccharomyces cerevisiae (ASCA) in patients with primary non-specific inflammations of the bowel

Epidemiologie, Mikrobiologie, Imunologie

Volumn 50, Issue 3, 2001, Pages 131-135

  Malickova K ^a   Janatkova I ^a   Fucikova T ^a   Adamec, S ^a   Lukas M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

ASCA; Crohn's disease; Inflammatory bowel disease; p ANCA; Saccharomyces cerevisiae; Ulcerative colitis

Indexed keywords

ALCOHOL; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; MANNAN; NEUTROPHIL CYTOPLASMIC ANTIBODY; BIOLOGICAL MARKER; FUNGUS ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL DISEASE; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SEROLOGY; ULCERATIVE COLITIS; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; MICROBIOLOGY;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

EID: 0034897962     PISSN: 12107913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Predictive value of serological screening tests in pediatric inflammatory bowel disease
2. Autoimunita na přelomu tisíciletí
3. Serologic testing for inflammatory bowel disease
4. Crohnova choroba a ulcerózní kolitida. K otázkám rizikových faktorù, etiologie a terapie nespecifických střevních zánětlivých chorob
5. Renální a urologické komplikace idiopatických střevních zánětů
6. Antibody to Saccharomyces cerevisiae (bakers" yeast) in Crohn's disease
7. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease
8. Antineutrophil cytoplasmic antibodies in inflammatory bowel diseases
9. Established and Emerging Biological Activity markers of Inflammatory Bowel Disease
10. The role of pANCA and ASCA in differentiating ulcerative colitis, Crohn's disease and indeterminate colitis
11. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role
12. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease and autoimmunine liver disease
13. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease
14. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel
15. Familial expression of anti-Saccharomyces cerevisiae manna antibodies in affected and unaffected relatives of patients with Crohn's disease
16. The utility of ANCA and ASCA in inflammatory bowel disease
17. New immunomodulating concepts in ANCA-associated disease
18. Diagnostic Approach to IBD